baber/WOPTO huggingface dataset:
Patent CA-2561152-C (CA)
Inventor: IHARA TOMOHIKO
IPC: C01B3/50
Filed: 2005-07-21
Granted: 2009-10-06
Abstract: A hydrogen permeable membrane (10) for selectively allowing hydrogen to permeate therethrough includes a metal base layer (12) containing vanadium (V), a metal coating layer (16) containing palladium (Pd), and an intermediate layer (14) that is formed between the metal base layer (12) and the metal coating layer (16) and made of a metal having a higher melting point than the metal base layer (12) and the metal coating layer (16) and possessing hydrogen permeability.
Patent CA-2564030-C (CA)
Title: Salt forms of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
Inventor: CAMPETA ANTHONY MICHAEL
IPC: C07D207/34
Filed: 2005-04-25
Granted: 2010-06-08
Abstract: Novel salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4~[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid characterized by their X-ray powder diffraction pattern and solid-state NMR  spectra are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease.
Patent CA-2566253-C (CA)
Inventor: KIRKUP MICHAEL G
IPC: H04L9/14
Filed: 2006-10-31
Granted: 2012-08-21
Abstract: In a system and method for authenticating a client device by an authentication device, the client device user is assigned a PIN generated by the authentication device. The user provides the PIN and a password to the client device, from which the client device generates a symmetric key and further generates a public/private key pair. The private key is encrypted using the symmetric key and stored in encrypted form only. The public key and a message authentication code generated from the PIN are provided to the authentication device, which stores the public key. Subsequently, when the user seeks to be authenticated, the user enters a password at the client device, which is used to generate a symmetric key to decrypt the encrypted private key. A message to the authentication device is signed using the resultant value. The authentication device uses the public key to verify the signature of the message.
Patent CA-2569425-C (CA)
Title: Verifying availability of idle-mode mobile subscriber station in wireless access system
Inventor: KIM BEOM JOON
IPC: H04W4/02
Filed: 2005-06-25
Granted: 2014-06-03
Abstract: A method of verifying availability of a mobile subscriber station that is in an idle-mode includes requesting to a base station by the mobile subscriber station to enter an idle-mode, wherein the base station is associated with a paging group comprising a plurality of base stations, and receiving from the base station an idle-mode response command to enter the idle-mode. The method also includes receiving from the base station a paging command comprising an action code associated with performing ranging while the mobile subscriber station is in the idle-mode to verify availability of the mobile subscriber station with respect to the base station, wherein if the ranging is not successfully performed with the base station during a pre-determined period, the base station continues to transmit the paging command until a paging retrial count reaches a predetermined threshold.
Patent CA-2574428-C (CA)
Title: System and method for determining rail safety limits
Inventor: HARRISON HAROLD
IPC: G06F17/00
Filed: 2005-07-26
Granted: 2009-10-27
Abstract: Methods, systems, and apparatus are disclosed for determining rail safety limits. A first example method is disclosed for determining rail safety limits, including identifying a target rail neutral temperature for a portion of continuous welded rail. The method also includes monitoring a longitudinal stress for the portion of continuous welded rail and monitoring an ambient rail temperature for the portion of continuous welded rail. The method further includes determining a present rail neutral temperature based on the longitudinal stress and the ambient rail temperature. According to the example method, the present rail neutral temperature is compared to the target rail neutral temperature to determine whether a failure of the portion of continuous welded rail has occurred, and an alert is reported if the difference between the present rail neutral temperature and the target rail neutral temperature is within a predetermined range. Other methods, apparatus, and systems are disclosed for presenting determining rail safety limits.
Patent CA-2576180-C (CA)
Title: Fuel cell casing with pressurizing hole
Inventor: TANAKA HIDEYUKI
IPC: H01M8/04
Filed: 2006-02-24
Granted: 2010-11-23
Abstract: In a fuel cell casing of the invention, a laminate structure of a first double-sided adhesive tape 36a, an interposed member 38, and a second double-sided adhesive tape 36b is placed between a casing body 22 and a depressurizing cover 34. In the fuel cell casing of this structure, adequate selection of the material for the interposed member 38 and adequate specification of an adhesion area of at least either the first double-sided adhesive tape 36a or the second double-sided adhesive tape 36b to the interposed member 38 readily attain the desired design of ensuring easy separation of the depressurizing cover 34 from the casing body 22 by simple application of a force to the depressurizing cover 34 under a preset level of inner pressure, without changing the materials of the casing body 22 and the depressurizing cover 34. Here the force applied to the depressurizing cover 34 under the preset level of the inner pressure may be insufficient for separation of the adhesive face of the first double-sided adhesive tape 36a from the casing body 22 and for separation of the adhesive face of the second double-sided adhesive tape 36b from the depressurizing cover 34.
Patent CA-2577667-C (CA)
Title: 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie
Inventor: METZ WILLIAM ARTHUR JR
IPC: C07D491/10
Filed: 2005-08-16
Granted: 2011-01-04
Abstract: The present invention discloses and claims compounds of formula (I) and formula (II) as inhibitors of human casein kinase I.epsilon., and methods of using said compounds of formula (I) and formula (II) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) or formula (II) are also disclosed and claimed.
Patent CA-2579209-C (CA)
Inventor: HOOPER CHARLES WILLIAM
IPC: B01J8/04
Filed: 2005-09-02
Granted: 2013-01-29
Abstract: A method of adapting an axial flow reaction vessel having opposed ports to an opposed axial flow reaction vessel is described comprising installing process fluid collection means within the body of the vessel in fluid communication with one or more of said ports.
Patent CA-2579637-C (CA)
Inventor: WAMPLER RICHARD K
IPC: A61M60/824
Filed: 2004-09-14
Granted: 2016-06-14
Abstract: Various "contactless" bearing mechanisms including hydrodynamic and magnetic bearings are disclosed for a pump (such as a pump for pumping blood), as alternatives to mechanical contact bearings. In one embodiment, a pump includes a housing assembly, center post, rotor, and rotor suspension system comprised of a passive magnetic bearing and hydrodynamic thrust bearing. The passive magnetic bearing is comprised of at least a first magnet assembly disposed in the rotor and a second magnet assembly disposed in the center post. The hydrodynamic thrust bearing is comprised of at least one contoured surface disposed between the rotor and housing assembly. The first and second magnetic assemblies each comprise at least one magnet. The first magnet assembly is pre-positioned to be offset axially from the second magnetic assembly to exert an axial biasing force on the rotor. A method of suspending a rotor in a pump during pumping is also disclosed.
Patent CA-2582462-C (CA)
Title: Prion protein binding materials and methods of use
Inventor: HAMMOND DAVID JOHN
IPC: A23L5/20
Filed: 2005-10-13
Granted: 2013-08-06
Abstract: Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.
Patent CA-2583155-C (CA)
Title: Selective hydrogenation catalyst
Inventor: HILL THOMAS
IPC: B01J37/16
Filed: 2005-10-13
Granted: 2013-07-09
Abstract: The invention relates to a catalyst on an oxidic carrier, and to methods for the selective hydrogenation of unsaturated compounds in hydrocarbon flows containing the same, using said catalysts.
Patent CA-2593776-C (CA)
Inventor: OZLUTURK FATIH M
IPC: H04W52/40
Filed: 1998-10-06
Granted: 2015-08-25
Abstract: A multicellular communications system where transmission between a roving subscriber and multiple base station transceivers is maintained throughout the territory. Each mobile subscriber unit has global code seeds for the entire communications system or an updated neighbor list and continuously searches to access available cell base stations while maintaining a communication link with one base station. Candidate cell base stations are interrogated and communicated with. The candidate base station that requires less transmitting energy from the mobile subscriber unit is closely monitored. When the mobile subscriber unit can successfully communicate with less transmit power than currently required by the present base station, the mobile subscriber unit is handed off to the candidate base station transceiver.
Patent CA-2598087-C (CA)
Inventor: NAG BISHWAJIT
IPC: C07D277/34
Filed: 2006-02-17
Granted: 2014-05-27
Abstract: Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance. (I) wherein represents an optional bond; W represents O or S; Z  represents CR10, O or S; G represents O, S or together with R10 forms a 5 or 6 membered aromatic or heteroaromatic ring system containing 1 or 2 heteroatoms selected from the group consisting of O, S and N; R8 represents OR13 or NR14R15; where R13 is selected from the group consisting of hydrogen, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl, (C5-C14) aryl, (C6-C34) aralkyl, (C1C13) heteroaryl, and a counter ion; and where R14 and R15 are independently selected from the group consisting of H, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl and (C5-C14) aryl; the other substituents are defined in the claims.
Patent CA-2602659-C (CA)
Inventor: MCDUFF PIERRE
IPC: F16B13/10
Filed: 2006-03-21
Granted: 2019-11-05
Abstract: An anchor assembly (A) for hollow walls comprises an anchor body (400) and a toggle member (231) that is displaceable between a first position wherein the toggle member (231) is substantially aligned with the anchor body (400) such that the anchor assembly (A) can be inserted in the wall (W) via a cutting distal end (325) of the toggle member (231), and a second position wherein the toggle member (231) extends behind the wall (W) at an angle relative to the anchor body (400) which extends through the wall (W). The toggle member (231) is held captive in the first position but is released and then rotated to the second position by a fastener (218) introduced in the anchor body (400). The fastener (218) threadably engages the toggle member (231) thereby drawing the toggle member (231) against a hidden side of the wall (W).
Patent CA-2606475-C (CA)
Inventor: HARRIS PAUL
IPC: C12N15/00
Filed: 2006-04-27
Granted: 2015-06-16
Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
Patent CA-2622811-C (CA)
Inventor: PELEMAN GUIDO
IPC: B42D3/00
Filed: 2006-10-02
Granted: 2012-12-04
Abstract: Method f or binding a bundle of loose leaves or the like in a cover ( 4 ) with a back ( 5 ) , characterised in that it mainly comprises the following steps :  - binding a f ree edge of the above-mentioned bundle of loose leaves (1) ; -providing the bundle of leaves ( 1 ) with its bound edge in the back ( 5 ) of the cover ( 4 ) and fixing this bundle ( 1 ) in the cover ( 4 ) .
Patent CA-2632118-C (CA)
Inventor: TAMMARO PRISCO
IPC: E04H9/10
Filed: 2006-09-11
Granted: 2011-03-08
Abstract: La présente invention concerne une ouverture de limitation de rayonnement pour une structure comprenant une porte munie d~un joint qui assure une étanchéité au niveau d~un encadrement de porte autour de l~ouverture. Des canaux espacés dans l~encadrement de porte définissent une gâche entre eux. Un film formé d~un matériau à compatibilité galvanique avec le joint pour éviter une corrosion est en contact étroit avec la gâche par un scellement. Ce scellement loge un bord du film dans chaque canal afin de créer un chemin tortueux pour le rayonnement.
Patent CA-2635327-C (CA)
Title: Dispensing device for single use
Inventor: KELLER WILHELM A
IPC: B67D7/70
Filed: 2006-12-07
Granted: 2014-08-12
Abstract: The dispensing device for single use includes a multicomponent cartridge (1), a mixer (8) having a mixer housing (9), as well as closure means for closing the outlets (4, 5) of the multicomponent cartridge. These closure means are connected to the mixer housing and comprise a respective closure stopper (13, 14) for each outlet that is insertable in an outlet (4, 5) of the multicomponent cartridge and is deformable such that upon rotation of the mixer housing relative to the cartridge, the closure stoppers (13, 14) are removed from the outlets (4, 5) of the multicomponent cartridge. Such an easily removable closure by means of deformable closure stoppers allows a very economical manufacture of dispensing devices that are intended to be used only once at it is required in medicine and in other fields.
Patent CA-2636648-C (CA)
Inventor: MYLLY KIMMO
IPC: G06F9/445
Filed: 2006-11-27
Granted: 2015-07-21
Abstract: Systems and methods for booting a host device(s) from a peripheral device(s) via an interface, such as an MMC/SD interface, with power terminals, a data bus with data bus terminals, a clock line with a clock terminal and a command line with command terminal. Power is provided to the power terminals, and the command terminal of the MMC/SD or analogous interface is set during power-up to low. The data bus is monitored for a start bit of data transmission.
Patent CA-2644887-C (CA)
Title: Systeme pour siege de vehicule et methode applicable
Inventor: PHIPPS PAUL B
IPC: B60N2/90
Filed: 2008-11-26
Granted: 2016-10-18
Abstract: Le système comprend un système de siège de véhicule comprenant un siège et au moins un actionneur de réglage pour siège motorisé pour modifier la position d'assise formée par le siège. En outre, le système comprend un système de freinage de véhicule comprenant des freins de véhicule et une pédale de frein. Le système comprend en outre un signal émis en réponse à l'application des freins du véhicule et/ou d'autres événements déclenchants tels que l'activation du signal de virage et d'autres qui conduisent à une suspension du mouvement de l'actionneur lors de l'application des freins du véhicule.
Patent CA-2646316-C (CA)
Inventor: GUTTRIDGE DENIS C
IPC: A61K31/00
Filed: 2007-03-15
Granted: 2016-05-24
Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-KB activation inhibitor capable of blocking the activation of NF-KB.
Patent CA-2648421-C (CA)
Title: Nasolacrimal drainage system implants for drug therapy
Inventor: DE JUAN EUGENE JR
IPC: A61F2/02
Filed: 2007-04-02
Granted: 2016-01-12
Abstract: Implant devices, systems and methods for insertion into a punctum of a patient optionally comprises a drug core and a sheath body disposed over the drug core. The drug core includes a therapeutic agent deliverable into the eye, and the sheath defines at least one exposed surface of the drug core. The exposed surface(s) of the drug core may contact a tear or tear film fluid and release the therapeutic agent at therapeutic levels over a sustained period when the implant is implanted for use. The implant may include a retention element to retain the drug core and sheath body near the punctum, optionally comprising a shape memory alloy that can resiliently expand. An occlusive element may be attached to the retention element to at least partially occlude tear flow through the canalicular lumen.
Patent CA-2648899-C (CA)
Inventor: CHAMEROY ERIC
IPC: A47J27/08
Filed: 2007-04-11
Granted: 2013-12-10
Abstract: The invention relates to an appliance for cooking food under pressure, the appliance being arranged to form a cooking enclosure having an orifice, a settable pressure-regulation valve, and adjustment means (25) for adjusting the setting of said valve, said adjustment means (25) being capable of moving between two positions, the appliance being characterized in that it includes an enclosure decompression control member capable of moving the settable pressure-regulation valve so that it opens the orifice, and in that it includes a setting adjustment member (32) capable of moving the setting adjustment means (25) to modify the value of the predetermined level.
Patent CA-2651276-C (CA)
Inventor: FAN JUNQIANG
IPC: G05B13/00
Filed: 2007-05-02
Granted: 2015-01-06
Abstract: A method includes receiving measurement data from at least one sensor (126, 128) at a first controller (104b). The measurement data is associated with a process. The method also includes receiving a first output signal at the first controller (104b). The first output signal is generated by a second controller (104a) and affects the process. The method further includes determining how to control at least a portion of the process using the measurement data and the first output signal. In addition, the method includes providing a second output signal, where the second output signal is operable to control at least the portion of the process. The second controller (104a) may be operable to use the second output signal to generate the first output signal.
Patent CA-2654312-C (CA)
Inventor: KANIA BRUCE G
IPC: A01G9/02
Filed: 2007-05-25
Granted: 2017-01-17
Abstract: A buoyant planter and its use. In one embodiment, the invention is a buoyant planter comprising: a nonwoven matrix body comprising fibers; a plurality of buoyant foam units integrated into said nonwoven matrix to produce a buoyant mass, said buoyant foam units being comprised of an expanded, cured polymer resin that envelopes a portion of said fibers to produce foamed zones; and a hydrophilic growth medium that is supported by said nonwoven matrix body. In another embodiment, the invention is a buoyant planter comprising: a nonwoven matrix body comprising fibers; a plurality of substantially vertical capillary channels within said nonwoven matrix body, each of said substantially vertical capillary channels having an upper end; and a grass sod disposed on said nonwoven matrix body and in communication with said upper ends.
Patent CA-2654751-C (CA)
Inventor: HOLLIMON CHARLES
IPC: F02K1/00
Filed: 2007-06-11
Granted: 2012-12-18
Abstract: An exhaust system for an aircraft has a primary exhaust duct for communicating exhaust gas from an engine exhaust exit and is configured for movement with the engine. A secondary exhaust duct is in fluid communication with the primary exhaust duct and is movably mounted to the airframe. The system has means for maintaining a generally consistent relative alignment between the primary duct and the secondary duct.
Patent CA-2658082-C (CA)
Inventor: OHUCHI MIHO
IPC: A61K47/34
Filed: 2007-04-25
Granted: 2015-03-17
Abstract: The invention provides a physiologically active polypeptide- or protein-encapsulating polymer micelle composition derived from a block copolymer comprising hydrophilic segments and hydrophobic segments.
Patent CA-2658555-C (CA)
Inventor: NGUYEN BINH
IPC: G07F17/32
Filed: 2007-07-31
Granted: 2017-06-20
Abstract: Various gaming-related services are provided, including but not limited to security services, harm minimization services, player identification services, bonusing/progressive services, accounting services, financial/banking services, network tunneling services, cheating detection services, etc. Such services may be provided, at least in part, by software agents that can be configured for different platforms and/or operating systems. Some software-based player tracking methods of the invention can aggregate data from multiple devices used by a player for gaming.
Patent CA-2667805-C (CA)
Inventor: PARK JU WON
IPC: H04L27/26
Filed: 2007-11-05
Granted: 2013-01-29
Abstract: In accordance with a detection method in a wireless communication system, an initial hypothesis for a starting position of a desired signal within a received wireless communication signal may be determined. The desired signal may have a conjugate symmetric property. At least one correlation value may be determined based on the initial hypothesis. The at least one correlation value may indicate the extent to which at least one sample sequence selected from the received signal has the conjugate symmetric property.
Patent CA-2672134-C (CA)
Title: Preparation medicale sous forme solide contenant un mannitol ou un lactose
Inventor: WATANABE TOMOYUKI
IPC: A61K47/10
Filed: 2007-12-06
Granted: 2015-02-10
Abstract: L'invention concerne une préparation médicale sous forme solide contenant un composé de formule générale (I) ou un sel pharmacologiquement acceptable de celui-ci. Cette préparation sous forme solide présente une homogénéité améliorée en termes de contenu. Elle contient (A) le composé de formule générale (I) ou un sel pharmacologiquement acceptable de celui-ci, et (B) un mannitol ou un lactose qui, analysé dans des conditions spécifiques, présente une distribution granulométrique caractérisée par un diamètre des particules compris entre 80 et 300 µm à 90% d'accumulation.
Patent CA-2673340-C (CA)
Inventor: CHORNET ESTEBAN
IPC: B01D53/14
Filed: 2007-12-10
Granted: 2012-10-23
Abstract: A method for co-producing a sulfur-containing raw synthetic gas and an essentially desulfurized solid residue from a sulfur-containing heavy petroleum residue feedstock, comprising feeding a bubbling fluidized-bed gasification reactor with the feedstock, and converting the feedstock to a raw synthetic gas by a partial oxidation reaction in the presence of water at a temperature at or below about 1000oC and a pressure at or below about 10 atm, thereby also producing an essentially desulfurized solid residue, while the sulfur components are essentially comprised in the raw synthetic gas; and separately recovering the essentially desulfurized solid residue and the sulfur-containing raw synthetic gas.